Myosin Va, a pivotal player in intracellular transport processes, can be modulated by a diverse array of chemical activators. Blebbistatin, a myosin II inhibitor, indirectly activates Myosin Va by modulating myosin II activity. Inhibition of myosin II influences actin-myosin dynamics, impacting downstream signaling and leading to enhanced Myosin Va activity in orchestrating intracellular transport processes. ML-7, a myosin light chain kinase (MLCK) inhibitor, indirectly activates Myosin Va by modulating the phosphorylation of myosin light chains. Inhibition of MLCK alters actin-myosin dynamics, influencing Myosin Va activity and its role in intracellular transport processes. CK-666 and CK-548, Arp2/3 complex inhibitors, indirectly influence Myosin Va by inhibiting actin nucleation. Inhibition of the Arp2/3 complex alters actin polymerization dynamics, impacting downstream signaling and leading to enhanced Myosin Va activity in orchestrating intracellular transport processes.
Latrunculin B, an actin polymerization inhibitor, disrupts actin dynamics and indirectly activates Myosin Va. Disruption of actin polymerization influences downstream signaling pathways, leading to enhanced Myosin Va activity and its involvement in intracellular transport processes. Y-27632, a ROCK inhibitor, indirectly influences Myosin Va by modulating Rho/ROCK signaling. Inhibition of ROCK alters cytoskeletal dynamics and downstream signaling, impacting Myosin Va activity and its role in intracellular transport processes. SMIFH2, a formin inhibitor, indirectly activates Myosin Va by modulating actin dynamics through formin inhibition. Altered actin dynamics influence downstream signaling pathways, leading to enhanced Myosin Va activity in orchestrating intracellular transport processes. Jasplakinolide, an actin stabilizer, indirectly activates Myosin Va by stabilizing actin filaments. Stabilization of actin filaments influences downstream signaling pathways, leading to enhanced Myosin Va activity in orchestrating intracellular transport processes. This comprehensive spectrum of Myosin Va activators illuminates the intricate pathways and cellular processes that govern intracellular transport dynamics, providing a foundation for further exploration in this realm.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Latrunculin B | 76343-94-7 | sc-203318 | 1 mg | $240.00 | 29 | |
Latrunculin B, an actin polymerization inhibitor, indirectly activates Myosin Va by disrupting actin dynamics. Disruption of actin polymerization influences downstream signaling pathways, leading to enhanced Myosin Va activity and its involvement in intracellular transport processes. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632, a ROCK (Rho-associated protein kinase) inhibitor, indirectly influences Myosin Va by modulating Rho/ROCK signaling. Inhibition of ROCK alters cytoskeletal dynamics and downstream signaling, impacting Myosin Va activity and its role in intracellular transport processes. | ||||||
SMIFH2 | 340316-62-3 | sc-507273 | 5 mg | $140.00 | ||
SMIFH2, a formin inhibitor, indirectly activates Myosin Va by modulating actin dynamics through formin inhibition. Altered actin dynamics influence downstream signaling pathways, leading to enhanced Myosin Va activity and its involvement in intracellular transport processes. | ||||||